01 1Arevipharma
01 1BUPRENORPHINE HYDROCHLORIDE
01 1Germany
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-19
Pay. Date : 2024-08-13
DMF Number : 40195
Submission : 2024-07-25
Status : Active
Type : II
20
Arevipharma Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BUPRENORPHINE HYDROCHLORIDE, with a corresponding US DMF Number 40195.
Remarkably, this DMF maintains an Active status since its submission on July 25, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 19, 2024, and payment made on August 13, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
